retatrutide clinical trial status retatrutide trials of subcutaneous tirzepatide, retatrutide, and Retatrutide for weight loss: Study

Gasbjerg LS, Helsted MM, Hartmann B, Jensen MH, Gabe MBN, Sparre-Ulrich AH, et al

Safety, Side Effects, and Medical Supervision Considerations Both semaglutide and tirzepatide carry similar safety profiles, with nausea, vomiting, and constipation as common early side effects that typically resolve within 2-4 weeks

Out of over 17,000 patients on Tirzepatide, 10 reported gastroparesis

For example, a composite nanozyme comprising carbon dots and Pt nanoparticles combines the high SOD-like activity of carbon dots with the robust catalase-like activity of Pt nanoparticles 154

Warnings: Keep out of the reach of children

Results may take 4-8 weeks to become noticeable